Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Phylogeography of Sodreaninae harvestmen (Arachnida: Opiliones: Gonyleptidae): Insights into the biogeography of the southern Brazilian Atlantic Forest.

Peres EA, Benedetti AR, Hiruma ST, Sobral-Souza T, Pinto-da-Rocha R.

Mol Phylogenet Evol. 2019 May 25;138:1-16. doi: 10.1016/j.ympev.2019.05.028. [Epub ahead of print]

PMID:
31136801
2.

Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice.

Perrier-Groult E, Pérès E, Pasdeloup M, Gazzolo L, Duc Dodon M, Mallein-Gerin F.

PLoS One. 2019 May 20;14(5):e0217183. doi: 10.1371/journal.pone.0217183. eCollection 2019.

3.

Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas.

Levallet G, Creveuil C, Bekaert L, Péres E, Planchard G, Lecot-Cotigny S, Guillamo JS, Emery E, Zalcman G, Lechapt-Zalcman E.

J Mol Diagn. 2019 May 2. pii: S1525-1578(18)30498-7. doi: 10.1016/j.jmoldx.2019.03.007. [Epub ahead of print]

PMID:
31055025
4.

TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.

Pigeon H, Pérès EA, Truillet C, Jego B, Boumezbeur F, Caillé F, Zinnhardt B, Jacobs AH, Le Bihan D, Winkeler A.

Neuro Oncol. 2019 Jun 10;21(6):755-764. doi: 10.1093/neuonc/noz029.

PMID:
30721979
5.

Insights into the evolutionary dynamics of Neotropical biomes from the phylogeography and paleodistribution modeling of Bromelia balansae.

Leal BSS, Medeiros LR, Peres EA, Sobral-Souza T, Palma-Silva C, Romero GQ, Carareto CMA.

Am J Bot. 2018 Oct;105(10):1725-1734. doi: 10.1002/ajb2.1167. Epub 2018 Oct 15.

PMID:
30324691
6.

Central line bundle maintenance among adults in a university hospital intensive care unit in São Paulo, Brazil: a best practice implementation project.

Sichieri K, Iida LIS, Menezes IRDSC, Garcia PC, Santos TR, Peres E, Shimoda GT, Maia FOM, Secoli SR, Püschel VAA.

JBI Database System Rev Implement Rep. 2018 Jun;16(6):1454-1473. doi: 10.11124/JBISRIR-2017-003561.

PMID:
29894411
7.

Longitudinal Study of Irradiation-Induced Brain Microstructural Alterations With S-Index, a Diffusion MRI Biomarker, and MR Spectroscopy.

Pérès EA, Etienne O, Grigis A, Boumezbeur F, Boussin FD, Le Bihan D.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1244-1254. doi: 10.1016/j.ijrobp.2018.01.070. Epub 2018 Feb 2.

8.

Biosorption of cationic dyes by Pará chestnut husk (Bertholletia excelsa).

Georgin J, Marques BS, Peres EC, Allasia D, Dotto GL.

Water Sci Technol. 2018 Mar;77(5-6):1612-1621. doi: 10.2166/wst.2018.041.

PMID:
29595163
9.

PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice.

Pérès E, Blin J, Ricci EP, Artesi M, Hahaut V, Van den Broeke A, Corbin A, Gazzolo L, Ratner L, Jalinot P, Duc Dodon M.

PLoS Pathog. 2018 Mar 22;14(3):e1006933. doi: 10.1371/journal.ppat.1006933. eCollection 2018 Mar.

10.

Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy.

Farhan S, Bazydlo M, Neme K, Mikulandric N, Peres E, Janakiraman N.

Adv Hematol. 2017;2017:8690416. doi: 10.1155/2017/8690416. Epub 2017 Nov 8.

11.

M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma.

Leblond MM, Pérès EA, Helaine C, Gérault AN, Moulin D, Anfray C, Divoux D, Petit E, Bernaudin M, Valable S.

Oncotarget. 2017 Aug 7;8(42):72597-72612. doi: 10.18632/oncotarget.19994. eCollection 2017 Sep 22.

12.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A.

Blood. 2017 Aug 31;130(9):1156-1164. doi: 10.1182/blood-2017-03-772368. Epub 2017 Jul 3.

13.

HTLV-1-induced leukotriene B4 secretion by T cells promotes T cell recruitment and virus propagation.

Percher F, Curis C, Pérès E, Artesi M, Rosewick N, Jeannin P, Gessain A, Gout O, Mahieux R, Ceccaldi PE, Van den Broeke A, Duc Dodon M, Afonso PV.

Nat Commun. 2017 Jun 22;8:15890. doi: 10.1038/ncomms15890.

14.

Nursing diagnoses in adult/elderly patients undergoing outpatient antineoplastic chemotherapy: a review.

Jomar RT, Gomes RAF, Leite DC, Gomes HF, Peres EM, Junior EFP.

Ecancermedicalscience. 2017 May 3;11:736. doi: 10.3332/ecancer.2017.736. eCollection 2017. Review.

16.

From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis.

Pérès E, Bagdassarian E, This S, Villaudy J, Rigal D, Gazzolo L, Duc Dodon M.

Viruses. 2015 Dec 7;7(12):6371-86. doi: 10.3390/v7122944. Review.

17.

Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.

Corroyer-Dulmont A, Pérès EA, Gérault AN, Savina A, Bouquet F, Divoux D, Toutain J, Ibazizène M, MacKenzie ET, Barré L, Bernaudin M, Petit E, Valable S.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):682-94. doi: 10.1007/s00259-015-3225-0. Epub 2015 Nov 5.

PMID:
26537287
18.

Pleistocene niche stability and lineage diversification in the subtropical spider Araneus omnicolor (Araneidae).

Peres EA, Sobral-Souza T, Perez MF, Bonatelli IA, Silva DP, Silva MJ, Solferini VN.

PLoS One. 2015 Apr 9;10(4):e0121543. doi: 10.1371/journal.pone.0121543. eCollection 2015.

19.

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.

Pérès EA, Gérault AN, Valable S, Roussel S, Toutain J, Divoux D, Guillamo JS, Sanson M, Bernaudin M, Petit E.

Oncotarget. 2015 Feb 10;6(4):2101-19.

20.

Enhanced Na⁺, K⁺-ATPase activity and endothelial modulation decrease phenylephrine-induced contraction in aorta from ouabain-treated normotensive and hypertensive rats.

Davel AP, Couto GK, Wenceslau CF, Peres EC, Xavier FE, Rossoni LV.

Horm Mol Biol Clin Investig. 2014 May;18(2):113-22. doi: 10.1515/hmbci-2013-0058.

PMID:
25390007
21.

One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J; Blood and Marrow Transplant Clinical Trials Network.

N Engl J Med. 2014 Oct 30;371(18):1685-94. doi: 10.1056/NEJMoa1405584.

22.

Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation.

Abedin S, Peres E, Levine JE, Choi S, Yanik G, Couriel DR.

Biol Blood Marrow Transplant. 2014 Dec;20(12):2062-6. doi: 10.1016/j.bbmt.2014.07.014. Epub 2014 Jul 18.

23.

IDH1(R132H) mutation increases U87 glioma cell sensitivity to radiation therapy in hypoxia.

Wang XW, Labussière M, Valable S, Pérès EA, Guillamo JS, Bernaudin M, Sanson M.

Biomed Res Int. 2014;2014:198697. doi: 10.1155/2014/198697. Epub 2014 May 7.

24.

Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.

Corroyer-Dulmont A, Pérès EA, Petit E, Durand L, Marteau L, Toutain J, Divoux D, Roussel S, MacKenzie ET, Barré L, Bernaudin M, Valable S.

Biol Chem. 2013 Apr;394(4):529-39. doi: 10.1515/hsz-2012-0318.

PMID:
23399636
25.

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Corroyer-Dulmont A, Pérès EA, Petit E, Guillamo JS, Varoqueaux N, Roussel S, Toutain J, Divoux D, MacKenzie ET, Delamare J, Ibazizène M, Lecocq M, Jacobs AH, Barré L, Bernaudin M, Valable S.

Neuro Oncol. 2013 Jan;15(1):41-56. doi: 10.1093/neuonc/nos260. Epub 2012 Oct 31.

26.

The recognition of web pages' hyperlinks by people with intellectual disabilities: an evaluation study.

Rocha T, Bessa M, Gonçalves M, Cabral L, Godinho F, Peres E, Reis MC, Magalhães L, Chalmers A.

J Appl Res Intellect Disabil. 2012 Nov;25(6):542-52. doi: 10.1111/j.1468-3148.2012.00700.x. Epub 2012 Sep 13.

PMID:
23055288
27.

A role for dendritic translation of CaMKIIα mRNA in olfactory plasticity.

Néant-Fery M, Pérès E, Nasrallah C, Kessner M, Gribaudo S, Greer C, Didier A, Trembleau A, Caillé I.

PLoS One. 2012;7(6):e40133. doi: 10.1371/journal.pone.0040133. Epub 2012 Jun 29.

28.

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.

Choi SW, Stiff P, Cooke K, Ferrara JL, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1525-32. doi: 10.1016/j.bbmt.2012.03.013. Epub 2012 Mar 30.

29.

Influence of eNOS gene polymorphism on cardiometabolic parameters in response to physical training in postmenopausal women.

Esposti RD, Sponton CH, Malagrino PA, Carvalho FC, Peres E, Puga GM, Novais IP, Albuquerque DM, Rodovalho C, Bacci M, Zanesco A.

Braz J Med Biol Res. 2011 Sep;44(9):855-63. Epub 2011 Aug 19.

30.

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.

Magenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P, Kitko C, Choi S, Yanik G, Frame D, Harris A, Erba H, Kujawski L, Elenitoba-Johnson K, Sanks J, Jones D, Paczesny S, Ferrara J, Levine J, Mineishi S.

Blood. 2011 Oct 13;118(15):4258-64. doi: 10.1182/blood-2011-06-358010. Epub 2011 Aug 12.

31.

Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.

Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, Kaminski M, Li C, Shedden K, Malek SN.

Blood. 2011 Sep 15;118(11):3051-61. doi: 10.1182/blood-2010-12-327858. Epub 2011 Jul 27.

32.

Targeting the erythropoietin receptor on glioma cells reduces tumour growth.

Pérès EA, Valable S, Guillamo JS, Marteau L, Bernaudin JF, Roussel S, Lechapt-Zalcman E, Bernaudin M, Petit E.

Exp Cell Res. 2011 Oct 1;317(16):2321-32. doi: 10.1016/j.yexcr.2011.06.011. Epub 2011 Jun 30.

PMID:
21749867
33.

Elafin is a biomarker of graft-versus-host disease of the skin.

Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash S, Ferrara JL.

Sci Transl Med. 2010 Jan 6;2(13):13ra2. doi: 10.1126/scitranslmed.3000406.

34.

Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.

Peres E, Levine JE, Khaled YA, Ibrahim RB, Braun TM, Krijanovski OI, Mineishi S, Abidi MH.

Bone Marrow Transplant. 2010 Jan;45(1):149-52. doi: 10.1038/bmt.2009.97. Epub 2009 May 25.

35.

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL.

Peres E, Braun T, Krijanovski O, Khaled Y, Levine JE, Yanik G, Kato K, Mineishi S.

Bone Marrow Transplant. 2009 Nov;44(9):579-83. doi: 10.1038/bmt.2009.61. Epub 2009 Mar 23.

PMID:
19308041
36.

Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.

Khaled Y, Mellacheruvu S, Reddy P, Peres E, Mineishi S.

Bone Marrow Transplant. 2009 Sep;44(5):325-6. doi: 10.1038/bmt.2009.14. Epub 2009 Feb 9. No abstract available.

PMID:
19204708
37.

Outcomes after auto-SCT in African Americans with multiple myeloma.

Khaled Y, Abidi MH, Janakiraman N, Kato K, Levine JE, Reddy P, Medina M, Peres E, Hanbali A, Mineishi S.

Bone Marrow Transplant. 2009 Jun;43(11):845-51. doi: 10.1038/bmt.2008.401. Epub 2009 Jan 12.

PMID:
19139731
38.

High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.

Peres E, Wood GW, Poulik J, Baynes R, Sood S, Abidi MH, Klein J, Bhambhani K, Dansey R, Abella E.

Neuropediatrics. 2008 Jun;39(3):151-6. doi: 10.1055/s-0028-1093333. Epub 2008 Nov 7.

PMID:
18991194
39.

Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline.

Peres E, Khaled Y, Krijanovski OI, Mineishi S, Levine JE, Kaul DR, Riddell J 4th.

Transpl Infect Dis. 2009 Feb;11(1):57-63. doi: 10.1111/j.1399-3062.2008.00351.x. Epub 2008 Oct 8.

40.

Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.

Peres E, Kintzel P, Dansey R, Baynes R, Abidi M, Klein J, Ibrahim RB, Abella E.

Blood Coagul Fibrinolysis. 2008 Apr;19(3):203-7. doi: 10.1097/MBC.0b013e3282f2b5d9.

PMID:
18388499
41.

[Immunization control and student registration at the city of São Paulo's Municipal Schools of Infantile Education].

de Silveira AS, da Silva BM, Peres EC, Meneghin P.

Rev Esc Enferm USP. 2007 Jun;41(2):299-305. Portuguese.

PMID:
17722398
42.

Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

Abidi MH, Tove I, Ibrahim RB, Maria D, Peres E.

Am J Hematol. 2007 Oct;82(10):932-3.

43.

Reduced intensity transplantation for metastatic renal cell cancer with 2-year follow-up.

Peres E, Abidi MH, Mellon-Reppen S, Klein J, Braun T, Abella E, Dansey R.

J Immunother. 2007 Jul-Aug;30(5):562-6.

PMID:
17589297
44.

Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.

Narreddy S, Mellon-Reppen S, Abidi MH, Klein JL, Peres E, Heilbrun LK, Smith D, Alangaden G, Chandrasekar PH.

Transpl Infect Dis. 2007 Mar;9(1):3-10.

PMID:
17313464
45.
46.

Palifermin in a hematopoietic stem cell transplant patient with osteonecrosis of the jaw.

Yageman LA, Cronin SM, Peres E, Abidi MH, Ibrahim RB.

J Oncol Pharm Pract. 2006 Jun;12(2):119-21.

PMID:
16984751
47.

The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.

Abidi MH, Kozlowski JR, Ibrahim RB, Peres E.

Hematol Oncol. 2006 Sep;24(3):164-5.

PMID:
16639690
48.

Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient.

Said A, Garnick JJ, Dieterle N, Peres E, Abidi MH, Ibrahim RB.

Pharmacotherapy. 2006 Feb;26(2):289-95.

PMID:
16466336
50.

Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.

Ibrahim RB, Peres E, Dansey R, Abidi MH, Abella EM, Gumma MM, Milan N, Smith DW, Heilbrun LK, Klein J.

Bone Marrow Transplant. 2005 Jun;35(11):1071-7.

PMID:
15821771

Supplemental Content

Support Center